Where innovation moves us
| Date - Category | Illustration | Title | Excerpt |
|---|---|---|---|
|
|
|
Spécialisée dans la conception de dispositifs médicaux implantés dans la colonne vertébrale, la société genevoise regroupe tous ses sites de production haut-savoyards à Reignier. Affichant une croissance annuelle à deux...
|
|
|
|
Spineart announces that it has reached the significant milestone of 100,000 Ti-LIFE Technology cages sold worldwide, supporting the Company’s mission to transform spine surgery for surgeons, patients and hospitals in...
|
|
|
|
Dallas, Texas, November 12, 2024 – Spineart, a leader in spine surgery innovation, unveils the Spineart Innovation Center in Dallas, Texas with a grand opening date of Thursday, November 14,...
|
|
|
|
ORANGE, Calif. July 25, 2024 – Providence St. Joseph Hospital announced it has successfully performed the world’s first robotic spinal surgery using a new open spine platform by eCential Robotics...
|
|
|
|
Geneva, Switzerland – June 28, 2024 – Spineart, a fast-growing company specialized in spine surgery innovation, is pleased to announce the appointment of Laurent Nodé-Langlois as Chief Technology Officer. In his...
|
|
|
|
Spineart proudly announces the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SCARLET® AC-Ti secured anterior cervical cage. The SCARLET® AC-Ti builds on a decade of...
|
|
|
|
SpinEM Robotics, a leading deep tech startup specializing in cutting-edge navigation solutions for robotic spinal surgery, is thrilled to announce a significant milestone in its innovation journey. The company has...
|
|
|
|
Spineart has successfully raised a CHF20 million convertible financing. The funding comes on the heels of the completion of enrollment in the two BAGUERA® C IDE studies, underlining Spineart’s commitment...
|
|
|
|
Spineart SA today announced it has completed enrollment in its U.S. IDE trial studying the BAGUERA®C Cervical Disc Prosthesis in patients with cervical disc disease at two contiguous levels between...
|
|
|
SPINEART completes enrollment in the BAGUERA® C IDE trial for single-level cervical disc replacement
|
Spineart SA, manufacturer of the BAGUERA®C Cervical Disc Prosthesis, is delighted to announce completion of enrollment in its U.S. IDE trial studying the BAGUERA®C Cervical Disc Prosthesis in patients with...
|
|
|
|
On September 1st, 2023, Spineart SA entered into a distribution agreement with Solco Biomedical of Republic of Korea. Since January 1st, 2024, Solco is the sole distributor of BAGUERA® C,...
|